Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,173.9
9.1 (0.29%)

 

  • STI Straits Times Index
    3,173.9
    9.1 (0.29%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,598.3
    5.8 (0.36%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,331.0
    368.4 (1.48%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,572.4
    14.1 (0.40%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,068.6
    517.7 (1.81%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,633.3
    7.2 (0.11%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,492.6M
  • Value: 1,237.8M
  • Rise: 199
  • Fall: 127
  • Unch: 425

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Hatten Land0.079+0.009
Rex Intl0.310+0.005
Genting Sing0.795+0.015
Ntegrator Intl0.009-
Geo Energy Res0.410-0.010
RH PetroGas0.205-
Sembcorp Marine0.080-
MarcoPolo Marine0.028-0.001
BlackGoldNatural0.019-
ThaiBev0.715+0.005

World Indices

World Indices
Name Last Change
Nasdaq 14,897.3 +73.9
HSI 25,331.0 +368.4
HSCEI 8,966.2 +117.0
Jakarta 6,633.3 +7.2
Nikkei 225 29,068.6 +517.7
SSE Comp 3,572.4 +14.1
Shanghai A 3,743.9 +14.8
Shanghai B 278.0 +0.5
KOSPI 3,015.1 +26.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Soho Global Health Tbk. SOHO GLOBAL HEALTH
Quotes 10 Minutes Delayed. Updated at 15 Oct 2021 15:05
Last (IDR): 5,050.000 Change: -25.000 High: 5,075.000 Remarks: -
Change (%): -0.49 Low: 5,050.000
Open 5,075.000 Yesterday's Close 5075.000
Buy Price 5050.000 Sell Price 5075.000
Buy Volume ('000) 1.3 Sell Volume ('000) 1.1
Cumulative Volume ('000) 2.4 Cumulative Value 12,150,000
Click to show Stock Prices chart

Key Statistics

EPS (IDR) a 135.60674 Trailing EPS (IDR) e 179.45823 NAV (IDR) b 1,723.7911
PE a 37.240 Trailing PE f 28.140 Price / NAV b 2.9296
Dividend (IDR) d 235.999673 Cash In Hand (IDR) g 517.5209 Issued & Paid-up Shares c 1,269,170,000
Dividend Yield (%) d 4.673 Price / Cash In Hand g 9.758 Treasury Shares h -
Beta - 75 Daysi -0.246 R-Squared - 75 Days(%)i 1.42 Market Cap (M) 6,409,308.500
Beta - 500 Daysi -0.162 R-Squared - 500 Days (%)i 0.14 Enterprise Value (M) 5,782,476.500
Piotroski F Score 8 Exchange Code SOHO Par Value ( IDR ) 500.00000
52 Weeks Volatility (%) 69.89 6-Month VWAP 5435.343 Free Float (%) 0.6
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 09 Sep 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 09 Sep 2020.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Soho Global Health Tbk. IDX 6,409,308.500 37.240 28.140 2.9296 4.673
Industry Pharmaceuticals: Major IDX 5,862,962.126 75.618 52.673 2.2059 1.623
Local Peer Kimia Farma Tbk. IDX 14,495,940.003 821.819 543.651 2.0641 0.049
Local Peer Merck Tbk. IDX 1,568,000.000 21.807 12.924 2.2586 3.486
Local Peer Phapros Tbk. IDX 978,600.000 20.182 14.085 1.3464 1.982
Global Peer JOHNSON & JOHNSON NYSE 424,619.024 28.858 23.899 6.1026 2.467
Global Peer PFIZER INC NYSE 232,621.568 24.191 17.586 3.3212 3.662
Global Peer ELI LILLY AND COMPANY NYSE 227,551.488 36.739 37.484 35.3100 1.244
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 202,860.219 24.982 22.555 3.7538 2.313
Global Peer MERCK & CO INC NYSE 198,282.212 28.057 35.592 5.9555 3.165
Global Peer ABBVIE INC NYSE 193,205.789 42.407 29.322 15.3715 4.422
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 186,577.819 58.379 49.477 11.9021 1.928
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 181,403.790 28.152 25.482 17.3508 1.314
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 129,682.340 - - 3.5232 3.184
Global Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 123,441.019 8.794 17.825 1.6460 2.738
Other Global Peers GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 (NYSE), WUXI APPTEC CO LTD (HKEx), TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), ROYALTY PHARMA PLC (NASDAQ), VIATRIS INC (NASDAQ), HANSOH PHARMACEUTICAL GROUP CO LTD (HKEx), REPLIGEN CORP (NASDAQ), INNOVENT BIOLOGICS INC (HKEx), CANSINO BIOLOGICS INC (HKEx), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), ORGANON & CO (NYSE), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), SINOPHARM GROUP CO. LTD. (HKEx), LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS (NASDAQ), CUREVAC NV (NASDAQ), REMEGEN CO LTD (HKEx), ALLAKOS INC (NASDAQ), SHANGHAI PHARMACEUTICALS HOLDING CO (HKEx), HUTCHMED (CHINA) LIMITED SPON ADS EACH REPR 5 ORD SHS (NASDAQ), HYGEIA HEALTHCARE HLDGS CO LTD (HKEx), HUTCHMED (CHINA) LIMITED (HKEx), CEREVEL THERAPEUTICS HLDGS INC (NASDAQ), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), SHANGHAI JUNSHI BIOSCIENCES CO LTD (HKEx), AKESO INC (HKEx), CHINA MEDICAL SYSTEM HLDGS LTD (HKEx), GUANGZHOU BAIYUNSHAN PHARMACEUTICAL (HKEx), INNOCARE PHARMA LTD (HKEx), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), IMMUNITYBIO INC (NASDAQ), REATA PHARMACEUTICALS INC (NASDAQ), ATEA PHARMACEUTICALS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), CARSGEN THERAPEUTICS HLDGS LTD (HKEx), CHINA RESOURCES PHARMACEUTICAL GR (HKEx), APELLIS PHARMACEUTICALS INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), CHINA GRAND PHARMACEUTICAL & HEALTH (HKEx), EMERGENT BIOSOLUTIONS INC (NYSE), SIMCERE PHARMACEUTICAL GRP LTD (HKEx), OPKO HEALTH INC (NASDAQ), CHINA TRADITIONAL CHINESE MED HLDGS (HKEx), TURNING POINT THERAPEUTICS INC (NASDAQ), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), ERASCA INC (NASDAQ), ATAI LIFE SCIENCES NV (NASDAQ), ADC THERAPEUTICS SA (NYSE), IGM BIOSCIENCES INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), SHANGHAI HENLIUS BIOTECH INC (HKEx), EVEREST MEDICINES LTD (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), SHENZHEN HEPALINK PHARMACEUTICAL (HKEx), DICERNA PHARMACEUTICALS INC. (NASDAQ), CENTESSA PHARMACEUTICALS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), SSY GROUP LIMITED (HKEx), OCUMENSION THERAPEUTICS (HKEx), CSTONE PHARMACEUTICALS (HKEx), DAY ONE BIOPHARMACEUTICALS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), GENERATION BIO CO (NASDAQ), UNITED LABORATORIES INTL HLDGS LTD (HKEx), OLEMA PHARMACEUTICALS INC (NASDAQ), ZYMEWORKS INC (NYSE), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), ABBISKO CAYMAN LTD (HKEx), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), PROCAPS GROUP S A (NASDAQ), CULLINAN ONCOLOGY INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), BEIJING TONG REN TANG CHINESE MEDIC (HKEx), BROOKLYN IMMUNO THERAPEUTICS INC (NYSE American), IMMUNOTECH BIOPHARM LTD (HKEx), FULCRUM THERAPEUTICS INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), KINNATE BIOPHARMA INC (NASDAQ), ICOSAVAX INC (NASDAQ), CONNECT BIOPHARMA HLDGS LTD ADS EACH REP ONE ORD SHARE (NASDAQ), KRONOS BIO INC (NASDAQ), SCICLONE PHARMACEUTICALS (HLDGS) LT (HKEx), CK LIFE SCIENCES INTL HLDG (HKEx), KEROS THERAPEUTICS INC (NASDAQ), PRAXIS PRECISION MEDICINES INC (NASDAQ), ANTENGENE CORP LTD (HKEx), IDEAYA BIOSCIENCES INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), TENAYA THERAPEUTICS INC (NASDAQ), ANNEXON INC (NASDAQ), TRANSCENTA HOLDING LTD (HKEx), GH RESEARCH PLC (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), MIND MEDICINE (MINDMED) INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), PETIQ INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), POINT BIOPHARMA GLOBAL INC (NASDAQ), CHINA SHINEWAY PHARMACEUTICAL GR (HKEx), VERU INC (NASDAQ), ALIGOS THERAPEUTICS INC (NASDAQ), BEYONDSPRING INC (NASDAQ), ALPHA TEKNOVA INC (NASDAQ), TALARIS THERAPEUTICS INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), TARSUS PHARMACEUTICALS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), NRX PHARMACEUTICALS INC (NASDAQ), ACUMEN PHARMACEUTICALS INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), CHINOOK THERAPEUTICS INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), HUA MEDICINE (HKEx), SIGA TECHNOLOGIES INC (NASDAQ), PHARVARIS NV (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), ADAGENE INC SPON ADS EACH REP 1.25 ORD SHS (NASDAQ), ZHAOKE OPHTHALMOLOGY LTD (HKEx), VACCITECH PLC ADR EACH REPR 1 ORD SH SPON (NASDAQ), BOLT BIOTHERAPEUTICS INC (NASDAQ), WEREWOLF THERAPEUTICS INC (NASDAQ), GRITSTONE BIO INC (NASDAQ), AC IMMUNE SA (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), IGBB (Bursa), EVELO BIOSCIENCES INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), EVOLUS INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), MINK THERAPEUTICS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), PYXIS ONCOLOGY INC (NASDAQ), CLENE INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), 89BIO INC (NASDAQ), ESSA PHARMA INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), RACE ONCOLOGY LTD (ASX), SILVERBACK THERAPEUTICS INC (NASDAQ), PYC THERAPEUTICS LIMITED (ASX), BIOMEA FUSION INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), CODIAK BIOSCIENCES INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), TOT BIOPHARM INTL CO LTD (HKEx), DAWNRAYS PHARMACEUTICAL HLDGS (HKEx), FUSION PHARMACEUTICALS INC (NASDAQ), CYBIN INC (NYSE American), TCR2 THERAPEUTICS INC (NASDAQ), ACHILLES THERAPEUTICS PLC ADS EACH REPR 1 SHARE SPON (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), ATHENEX INC (NASDAQ), XOMA CORP (NASDAQ), AFT PHARMACEUTICALS LTD (ASX), NEXIMMUNE INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), BSTEAD (Bursa), CHECKPOINT THERAPEUTICS INC (NASDAQ), FUSEN PHARMACEUTICAL CO LTD (HKEx), DURECT CORP (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), HARROW HEALTH INC (NASDAQ), VINCERX PHARMA INC (NASDAQ), PHARMA (Bursa), ANGION BIOMEDICA CORP (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), REGENCELL BIOSCIENCE HLDGS LTD (NASDAQ), TRICIDA INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), OBSEVA SA (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), IMMUNIC INC (NASDAQ), ANNOVIS BIO INC (NYSE American), IMPEL NEUROPHARMA INC (NASDAQ), VECTIVBIO HLDG AG (NASDAQ), INOZYME PHARMA INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), MUSTANG BIO INC (NASDAQ), ALZAMEND NEURO INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), IP (SET), 180 LIFE SCIENCES CORP (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), 4D PHARMA PLC SPONS ADR EACH REP 8 ORD SHS (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), ANEBULO PHARMACEUTICALS INC (NASDAQ), LIQUIDIA CORPORATION (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), RENEO PHARMACEUTICALS INC (NASDAQ), CHINA BIOTECH SERVICES HLDGS LTD (HKEx), SATSUMA PHARMACEUTICALS INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), NOVAN INC (NASDAQ), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), POLYPID LTD (NASDAQ), F-STAR THERAPEUTICS INC (NASDAQ), EYENOVIA INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), IX Biopharma (SGX), ENTERA BIO LTD (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), ZHONGZHI PHARMACEUTICAL HLDGS LTD (HKEx), VTV THERAPEUTICS INC (NASDAQ), RECCE PHARMACEUTICALS LTD (ASX), CLARUS THERAPEUTICS HLDGS INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), NOXOPHARM LTD (ASX), GENPREX INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), LANNETT CO INC (NYSE), KOTRA (Bursa), EDESA BIOTECH INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), TEMPEST THERAPEUTICS INC (NASDAQ), CRESO PHARMA LTD (ASX), IMARA INC (NASDAQ), CHARMACY PHARMACEUTICAL CO LTD (HKEx), MEDIWOUND LTD (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), NEW RAY MEDICINE INTL HLDG LTD (HKEx), YUMANITY THERAPEUTICS INC (NASDAQ), GALECTO INC (NASDAQ), PROPHASE LABS INC (NASDAQ), ELEDON PHARMACEUTICALS INC (NASDAQ), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), GRAYBUG VISION INC (NASDAQ), AYTU BIOPHARMA INC (NASDAQ), OCUPHIRE PHARMA INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), SYNAPTOGENIX INC (NASDAQ), SANAI HEALTH INDUSTRY GP CO LTD (HKEx), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), NEW CENTURY HEALTHCARE HLDGS CO LTD (HKEx), PAK FAH YEOW INTERNATIONAL (HKEx), Hyphens Pharma (SGX), MANNATECH INC (NASDAQ), NOVA (Bursa), ABVC BIOPHARMA INC (NASDAQ), BONE BIOLOGICS CORP (NASDAQ), EXOPHARM LTD (ASX), VYNE THERAPEUTICS INC (NASDAQ), INVION LTD (ASX), BIOHLDG (Bursa), MODERN CHINESE MEDICINE GRP CO LTD (HKEx), VIRPAX PHARMA INC (NASDAQ), SHENZHEN NEPTUNUS INTERLONG BIO-TEC (HKEx), WAI YUEN TONG MEDICINE HOLDINGS LTD (HKEx), UNIVERSE PHARMACEUTICALS INC (NASDAQ), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), RENOVORX INC (NASDAQ), ACURX PHARMACEUTICALS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), INHIBIKASE THERAPEUTICS INC (NASDAQ), BAUDAX BIO INC (NASDAQ), VALLON PHARMACEUTICALS INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), PURAPHARM CORPORATION LIMITED (HKEx), ARIDIS PHARMACEUTICAL INC (NASDAQ), SEQLL INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), PHARMAXIS (ASX), MEDLAB CLINICAL LIMITED (ASX), VIRIOS THERAPEUTICS INC (NASDAQ), PASITHEA THERAPEUTICS CORP (NASDAQ), XORTX THERAPEUTICS INC (NASDAQ), DERMATA THERAPEUTICS INC (NASDAQ), PALLA PHARMA LTD (ASX), AGEX THERAPEUTICS INC (NYSE American), ACER THERAPEUTICS INC (NASDAQ), JCT (SET), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), EXTRAWELL PHARMACEUTICAL HLDGS (HKEx), SUNZEN (Bursa), NLS PHARMACEUTICS LTD (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), PAINREFORM LTD (NASDAQ), PANBELA THERAPEUTICS INC (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), TIMBER PHARMACEUTICALS INC (NYSE American), ACRUX (ASX), IMMURON LIMITED (ASX), AVENUE THERAPEUTICS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), NANJING SINOLIFE UNITED COMPANY LTD (HKEx), TALI DIGITAL LIMITED (ASX), ISLAND PHARMACEUTICALS LTD (ASX), TITAN PHARMACEUTICAL INC (NASDAQ), SUDA PHARMACEUTICALS LTD (ASX), PETROS PHARMACEUTICALS INC (NASDAQ), TELIGENT INC NEW (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), PA SHUN INTERNATIONAL HOLDINGS LTD (HKEx), FIJI KAVA LTD (ASX), FARMAFORCE LTD (ASX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --50.000
-0.98 %
10 Days -+50.000
+1.00 %
20 Days --125.000
-2.42 %
Medium Term Return 3 Months 197.000-
+3.90 %
6 Months 433.000+410.000
+18.17 %
1 Year 433.000-650.000
-3.81 %
Annualised Return Annualised --
-3.81 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 4,420.000 - 7,750.000 Change From 1 Year Low +630.000 % Change From 1 Year Low (%) +14.25
Change From 1 Year High -2700.000 % Change From 1 Year High (%) -34.84
2 Years Range 2,270.000 - 16,300.000 Change From 2 Years Low +2780.000 % Change From 2 Years Low (%) +122.47
Change From 2 Years High -11250.000 % Change From 2 Years High (%) -69.02
5 Years Range 2,270.000 - 16,300.000 Change From 5 Years Low +2780.000 % Change From 5 Years Low (%) +122.47
Change From 5 Years High -11250.000 % Change From 5 Years High (%) -69.02
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

PT SOHO Global Health engages in the provision of healthcare services. Its businesses include toll manufacturing, network marketing, medical devices, alliance and in-licensing, distribution, and consumer health. Its products comprise of Curcuma Plus, Curcuma Plus Milk, Imboost, Fitkom, Diapet, Laxing, Lelap, Asthma Soho, and Sohobion. The company was founded on August 27, 1956 and is headquartered in Jakarta, Indonesia.

Historical Price Data

Date Open High Low Close Volume VWAP
15 Oct 2021 5075.000 5075.000 5050.000 5050.000 2,400 5062.5000
14 Oct 2021 5050.000 5075.000 5050.000 5075.000 2,100 5058.3333
13 Oct 2021 5025.000 5075.000 5025.000 5075.000 2,400 5027.0833
12 Oct 2021 5025.000 5050.000 5025.000 5025.000 7,200 5044.7917
11 Oct 2021 5100.000 5100.000 5000.000 5050.000 4,700 5035.6383
08 Oct 2021 5075.000 5100.000 5050.000 5100.000 1,400 5071.4286
07 Oct 2021 5050.000 5100.000 5025.000 5100.000 3,800 5069.0789
06 Oct 2021 5075.000 5100.000 5025.000 5050.000 3,900 5042.3077
05 Oct 2021 5025.000 5100.000 5025.000 5025.000 5,100 5080.8824
04 Oct 2021 5000.000 5100.000 5000.000 5025.000 5,000 5068.0000
01 Oct 2021 5000.000 5075.000 5000.000 5000.000 4,600 5038.0435
30 Sep 2021 5025.000 5050.000 5000.000 5000.000 18,800 5019.1489
29 Sep 2021 5075.000 5100.000 5000.000 5050.000 14,500 5028.2759
28 Sep 2021 5075.000 5100.000 5050.000 5075.000 6,400 5089.0625
27 Sep 2021 5150.000 5200.000 5050.000 5050.000 8,600 5140.9884
24 Sep 2021 5050.000 5200.000 5050.000 5200.000 3,900 5061.5385
23 Sep 2021 5075.000 5075.000 5025.000 5025.000 6,600 5050.7576
22 Sep 2021 5075.000 5075.000 5025.000 5025.000 17,000 5061.7647
21 Sep 2021 5100.000 5125.000 5075.000 5100.000 11,000 5101.3636
20 Sep 2021 5200.000 5200.000 5175.000 5175.000 1,200 5191.6667
17 Sep 2021 5125.000 5175.000 5125.000 5175.000 1,000 5130.0000
16 Sep 2021 5150.000 5150.000 5125.000 5125.000 1,600 5139.0625
Summary
Current 2 Weeks
(04 Oct 2021 to 15 Oct 2021)
5000.000 5100.000 5000.000 5050.000 38,000 -
Previous 2 Weeks
(20 Sep 2021 to 01 Oct 2021)
5200.000 5200.000 5000.000 5000.000 92,600 -
4 Weeks from
(23 Aug 2021 to 17 Sep 2021)
5100.000 5200.000 5000.000 5175.000 195,200 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.